SLC5A2 and kidney disorder: Not only were baseline TNFR levels associated with the progression of kidney disease, but also a smaller difference in TNFR levels between baseline and 1 year after SGLT2 inhibitor treatment was associated with better subsequent kidney outcomes22,23.